Financials - Evogene

Financials

2025

Q3 2025 Consolidated Financial Statements
Q2 2025 Consolidated Financial Statements
Q1 2025 Consolidated Financial Statements

2024

Annual report 2024 – 20-F
Q4 2024 Consolidated Financial Statements
Q3 2024 Consolidated Financial Statements
Operating and Financial Review and Prospects_as of_and for the six month ended June 30 2024
Q2 2024 Consolidated Financial Statements
Q1 2024 Consolidated Financial Statements
2024 Annual General Meeting of Shareholders

2023

Annual Report 2023 – 20-F
Q4 and Full Year 2023 Consolidated Financial Statements
Q3 2023 Consolidated Financial Statements
Interim Financial Statements and MD&A for the Six Months Ended June 30, 2023
Q2 2023 Consolidated Financial Statements
Q1 2023 Consolidated Financial Statements

2022

Annual report 2022 – 20-F
Q4 and Full Year 2022 Consolidated Financial Statements
Q3 2022 Consolidated Financial Statements
Q2 2022 Consolidated Financial Statements
Q1 2022 Consolidated Financial Statements

2021

Annual report 2021 – 20-F
Q4 2021 Consolidated Financial Statements
Q3 2021 Consolidated Financial Statements
Q2 2021 Consolidated Financial Statements
Q1 2021 Consolidated Financial Statements

2020

Annual report 2020 – 20-F
Q3 2020 Consolidated Financial Statements
Q2 2020 Consolidated Financial Statements
Q1 2020 Consolidated Financial Statements